A BBC star is taking a temporary step back from his role on BBC's Morning Live to work for a fat-jab company alongside Coleen ...
Nabla and Takeda first joined hands in 2022, to push “the boundaries of next-generation biologics discovery,” according to ...
Guardant Health faces high valuation, reimbursement, and scaling risks, warranting caution for investors. Learn why GH stock is a Buy.
CNW/ - One in five Albertans live with a lung condition, yet access to critical testing is limited in many rural and remote communities. This lack of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback